Vantage Investment Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | $1K | Hold |
572
| – | – | ﹤0.01% | 730 |
|
2018
Q2 | $1K | Hold |
572
| – | – | ﹤0.01% | 728 |
|
2018
Q1 | $1K | Hold |
572
| – | – | ﹤0.01% | 773 |
|
2017
Q4 | $1K | Hold |
572
| – | – | ﹤0.01% | 790 |
|
2017
Q3 | $1K | Hold |
572
| – | – | ﹤0.01% | 768 |
|
2017
Q2 | $2K | Hold |
572
| – | – | ﹤0.01% | 709 |
|
2017
Q1 | $2K | Hold |
572
| – | – | ﹤0.01% | 703 |
|
2016
Q4 | $2K | Hold |
572
| – | – | ﹤0.01% | 709 |
|
2016
Q3 | $2K | Hold |
572
| – | – | ﹤0.01% | 693 |
|
2016
Q2 | $1K | Hold |
572
| – | – | ﹤0.01% | 772 |
|
2016
Q1 | $1K | Sell |
572
-48
| -8% | -$84 | ﹤0.01% | 762 |
|
2015
Q4 | $2K | Hold |
620
| – | – | ﹤0.01% | 700 |
|
2015
Q3 | $2K | Hold |
620
| – | – | ﹤0.01% | 708 |
|
2015
Q2 | $2K | Sell |
620
-619
| -50% | -$2K | ﹤0.01% | 685 |
|
2015
Q1 | $5K | Buy |
1,239
+619
| +100% | +$2.5K | ﹤0.01% | 686 |
|
2014
Q4 | $2K | Hold |
620
| – | – | ﹤0.01% | 703 |
|
2014
Q3 | $2K | Hold |
620
| – | – | ﹤0.01% | 655 |
|
2014
Q2 | $2K | Hold |
620
| – | – | ﹤0.01% | 648 |
|
2014
Q1 | $2K | Hold |
620
| – | – | ﹤0.01% | 605 |
|
2013
Q4 | $2K | Buy |
+620
| New | +$2K | ﹤0.01% | 582 |
|